Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07802340 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficiency of Asiaticoside as Intracanal Medication in Revascularization Process

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Start date pushed from Sep 15, 2026 to Oct 1, 2026 Primary completion date: Jan 2027 to Feb 2027 · Completion date: Jan 2028 to Feb 2028 Show 2 more changesShow less
    • Primary completion date: Jan 2027 to Feb 2027
    • Completion date: Jan 2028 to Feb 2028
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study assess the ability of Asiaticoside based Intracanal medication compared to the commonly used Intracanal medicament ( calcium hydroxide Ca(OH) 2) on the outcome of the revascularization process in immature permanent teeth with pulp necrosis
Trial Details
NCT Number NCT07802340
Lead Sponsor Mansoura University
Conditions Immature Permanent Teeth With Open Apex, Pulp Necrosis
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov